Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits

Current Eye Research

Volumn 15, Issue 5, 1996, Pages 569-576

  Cundy, Kenneth C ^a   Lynch, Geoffrey ^a   Shaw, Jeng Pyng ^a   Hitchcock, Michael J M ^a   Lee, William A ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

Cidofovir; Cyclic 1 (S) 3 hydroxy 2(phosphonomethoxy)propyl cytosine (HPMPC); Distribution; Intravitreal; Rabbit

Indexed keywords

ANTIVIRUS AGENT; CARBON 14; CIDOFOVIR; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; EYE; INTRAVITREAL DRUG ADMINISTRATION; KIDNEY; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RETINA;

EID: 0029977522     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.3109/02713689609000768     Document Type: Article

References (21)

1. McKenzie, R., Travis, W. D., Dolan, S. A., Pittaluga, S., Feuerstein, I. M., Shelhamer, J., Yarchoan, R. and Masur, H. (1991) The causes of death in patients with human immunodeficiency virus infection: a clinical and pathologic study with emphasis on the role of pulmonary disease. Medicine, 70, 326-343.
2. AIDS Ophthalmology Study Group. Studies of Ocular Complications of AIDS Research Group. (1992) Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N. Engl. J. Med. 326, 213-220.
3. Cantrill, H. L., Henry, K., Melroe, N. H., Knobloch, W. H., Ramsay, R. C. and Balfour, H. H. (1989) Treatment of cytomegalovirus retinitis with intravitreal ganciclovir; long term results. Ophthalmology, 96, 367-374.
4. Krishnamoorthy, R., Hughes, P. M. and Mitra, A. K. (1994) The effect of ocular pigmentation in the vitreous disposition and elimination of acycloguanosine analogs. (Abstract). Pharm. Res. 11 (Suppl.), S424.
5. Bronson, J. J., Ferrara, L. M., Hitchcock, M. J. M., Ho, H-T., Woods, K. L., Ghazzouli, I., Kern, E. R., Soike, K. F. and Martin, J. C. (1990) (S)-1-(3-Hydroxy-2-(phosphonylmethoxy)propyl) cytosine (HPMPC): a potent antiherpesvirus agent. Adv. Exp. Med. Biol. 278, 277-283.
6. Ho, H-T., Woods, K. L., Bronson, J. J., De Boeck, H., Martin, J. C. and Hitchcock, M. J. M. (1991) Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Molec. Pharmacol. 41, 197-202.
7. Lalezari, J. P., Drew, W. L., Glutzer, E., James, C., Miner, D., Flaherty, J., Fisher, P. E., Cundy, K. C., Hannigan, J., Martin, J. C. and Jaffe, H. S. (1995) (S)-1-[3-Hydroxy2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. J. Infect. Dis. 171, 788-796.
8. Polis, M. A., Spooner, K. M., Baird, B. F., Manishewitz, J. F., Jaffe, H. S., Fisher, P. F., Falloon, J., Davey, Jr., R. T., Kovacs, J. A., Walker, R. E., Whitcup, S. M., Nussenblatt, R. B., Lane, H. C. and Masur, H. (1995) Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria. Antimicrob. Agents Chemother. 39, 882-886.
9. Dolnak, D. R., Munguia, D., Wiley, C. A., De Clercq, E., Bergeron-Lynn, G. L., Boscher, C., Connor, J. D., Sherwood, C. , Capparelli, E., Armani, R. and Freeman, W. R. (1992) Lack of retinal toxicity of the anticytomegalovirus drug (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine. Invest. Ophthalmol. Vis. Sci. 33, 1557-1563.
10. Flores-Aquilar, M., Huang, J-S., Wiley, C. A., De Clercq, E., Vuong, C., Bergeron-Lynn, G., Chandler, B., Munguia, D. and Freeman, W. R. (1994) Long-acting therapy of viral retinitis with (S)-1-(3-Hydroxy-2-phosphonyl-methoxypropyl)cytosine. J. Infect. Dis. 169, 642-647.
11. Kirsch, L. S., Arevalo, J. F., De Clercq, E., de la Paz, E. C., Munguia, D., Garcia, R. and Freeman, W. R. (1995) A phase I/II study of intravitreal cidofovir (HPMPC) for the treatment of cytomegalovirus retinitis in patients with the acquired immune deficiency syndrome. Am. J. Ophthalmol. 119, 466-476.
12. Kirsch, L. S., Arevalo, J. F., de la Paz, E. C., Munguia, D., De Clercq, E. and Freeman, W. R. (1995) Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology, 102, 533-542.
13. Bischofberger, N., Hitchcock, M. J. M., Chen, M. S., Cundy, K. C., Barkhimer, D., Kent, K. M., Lacy, S. A., Lee, W. A., Li, Z-H., Louie, M., Mendel, D. B., Smee, D. S. and Smith, J. L. (1994) Cyclic HPMPC: an intracellular prodrug for HPMPC with improved therapeutic index in vivo. Antimicrob. Agents Chemother. 38, 2387-2391.
14. Hitchcock, M. J. M., Lacy, S. A., Lindsay, J. R. and Kern, E. (1995) The cyclic congener of cidofovir has reduced nephrotoxicity in three species. (Abstract). Antiviral Res. 26, A358.
15. Holy, A. and Rosenberg, I. (1987) Synthesis of 9-(2-phosphonyl-methoxyethyl)adenine and related compounds. Collect. Czech. Chem. Commun. 52, 2801-2806.
16. Cihlar, T., Votruba, I., Horska, K., Liboska, R., Rosenberg, I. and Holy, A. (1992) Metabolism of 1-(s)-(3-hydroxy-2-phosphonomethoxypropyl)-cytosine (HPMPC) in human embryonic lung cells. Collect. Czech. Chem. Commun. 57, 661-672.
17. Lee, W. A., Shaw, J-P., Bidgood, A. M., Lynch, G., Eisenberg, E. and Cundy, K. C. (1995) Tissue distribution and bioavailability of cyclic HPMPC, an intracellular prodrug of HPMPC. (Abstract). Antiviral Res. 26, A340.
18. Barza, M., Kane, A. and Baum, J. (1982) The effects of infection and probenecid on the transport of carbenecillin from the rabbit vitreous humor. Invest. Ophthalmol. Vis. Sci. 22, 720-726.
19. Doft, B. H., Weiskopf, J., Nilsson-Ehle, I. and Wingard Jr, I. (1985) Amphotericin clearance in vitrectomized versus nonvitrectomized eyes. Ophthalmology, 92, 1601-1605.
20. Leeds, J. M., Kornbrust, D., Truong, L. and Henry, S. (1994) Metabolism and pharmacokinetic analysis of a phosphorothioate oligonucleotide after intravitreal injection. (Abstract). Pharm. Res. 11 (Suppl.), S353.
21. Cundy, K. C., Li, Z-H. and Lee, W. A. (1994) Effect of concomitant probenecid on the tissue distribution and urinary excretion of HPMPC in preclinical models. (Abstract). Pharm. Res. 11 (Suppl.), S449.